Scipher Medicine

This week Scipher Medicine presented at EULAR 2024 in Vienna, Austria. The technology behind Prism RA Test and the impact that the test is having on treatment selection in RA is pushing precision medicine forward for autoimmune patients.

Scipher Medicine® Showcases New Data at EULAR 2024 - Scipher Medicine WALTHAM, Mass., June 13, 2024 Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, is attending and presenting at the annual European Alliance of Associations for Rheumatology (EULAR) conference in Vienna, Austria. The poster present...

Scipher’s CEO & President, Reg Seeto, CTO, Slava Akmaev, and Ingo Chakarvarty are looking forward to joining over 500 public & private healthcare companies, investors, and VCs at this year’s Jefferies Global Healthcare Conference.

Join us at BIO 2024 June 3-6 in San Diego, CA where Scipher’s executive leadership team will be meeting with leaders across the industry to showcase our unique Spectra Platform and the invaluable strides its making in precision medicine.

This week Scipher’s own Uday Shanthamallu presented a poster at Digestive Disease Week in Washington DC. The research behind this poster continues to bring Scipher’s unique intelligence to precision medicine for treatment of autoimmune diseases such as Ulcerative Colitis.



Link:

Identifying TNFI Therapy Response in UC Patients Using Baseline Whole Blood Gene Expression Data - Scipher Medicine Shanthamallu, Uday Shankar ; Jones, Alexander ; Panés, Julián ; Corraliza Márquez, Ana Maria ; Salas, Azucena ; Akmaev, Slava ; Ghiassian, Susan Dina Background Non-response to TNF inhibitor (TNFi) therapies remains a challenge in UC/IBD management. Identification of non-responders before initiat...

Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence.

Scipher Medicine is proud to welcome Reginald Seeto as our new President and CEO. His unique background and vision for the future are the perfect combination for Scipher’s next phase of growth. Welcome Reg!

Today we are launching an updated look & feel for Scipher Medicine. The brighter color pallet aligns with our vision of hope and using our network science to help those who are suffering in silence.

https://www.sciphermedicine.com/

Scipher Medicine acquires CrossBridge and its SaaS platform to collect and map patient molecular, outcomes and claims data in real-time. 

- First-of-its-kind technology stack in autoimmune diseases. 
- Provides unprecedented insights into optimal patient treatment pathway.

Read more: https://bit.ly/3GW2xao

We are proud to be recognized in the 2022 BioTech Breakthrough Awards, taking home the Immunology Innovation of the Year award for our work to match each patient to their most effective treatment. The BioTech Breakthrough Awards highlight breakthrough products, solutions and companies in biotech and life sciences. https://tinyurl.com/y7da5ken

Scipher has been named a 2022 Red Herring Top 100 Global winner. Red Herring’s Top 100 Global list has become a mark of distinction for identifying promising companies and outstanding entrepreneurs from North America, Europe, and Asia. We are proud to be recognized along with other exciting and innovative companies on this year’s list. https://tinyurl.com/5n7s89px

Data Engineer Marco Perez shares what he likes about working at Scipher Medicine.

Via the AWS Health Innovation Podcast: Our CMO Sam Asgarian talks with Joe Shonkwiler about Scipher's mission to match each patient with their most effective therapy and why healthcare innovation differs from other industries and verticals. Tune in: https://apple.co/3gfmtd3

‎AWS Health Innovation Podcast on Apple Podcasts ‎Technology · 2022

Today is . Millions of people are impacted by this disease worldwide, including 1.6 million people in the U.S with rheumatoid arthritis. Learn more about our work to help them: sciphermedicine.com

In celebration of National Hispanic Heritage Month, Client Services Associate Luis Merino shares what the month means to him.

Congrats to our team! Scipher Medicine is an honoree on this year's BostInno on Fire list. We are proud to join a cohort of companies that have demonstrated their success in raising funds, launching new products, bringing in new customers, growing their footprint, and supporting the local community and innovation ecosystem.

BostInno's 2022 Inno on Fire Meet the 50 companies lighting up Boston's startup ecosystem.

Our mission is to match each patient with their most effective therapy. Learn more at sciphermedicine.com

Today is the first day of National Hispanic Heritage Month. In honor of the month, we recognize the achievements and contributions of our Hispanic American teammates and others who have inspired others to succeed. Learn more: http://ow.ly/x1Le50KKzlt

National Hispanic American Heritage Month 2022 Paying tribute to the generations of Hispanic Americans who have positively influenced and enriched our nation and society.

Our CMO Sam Asgarian talked about precision medicine and our Prism RA Test test: “You are treating based on their individual biology, and therefore, you have the ability to be more targeted in your treatment.” Via Radio Health Journal

Ending the Trial and Error Treatment Method for Rheumatoid Arthritis Many patients with rheumatoid arthritis are forced to try numerous, expensive medications. Scipher Medicine’s new blood test offers a precision approach, discovering what medication will work the first time.

Via Ivanhoe Broadcast News: "The holy grail of rheumatology has been ... how do you know which drug will work for whom?" Rheumatologist Dr. Sylvia Ross talks about our Prism RA Test and what it means for her patients. Watch now:

PrismRA Takes the Guesswork Out of Rheumatoid Arthritis Treatment - Ivanhoe Broadcast News, Inc. Rheumatoid arthritis is a progressive autoimmune disease that if untreated, can attack the joints, and internal organs. There are medications that can help block the inflammation, but finding the right therapy is often trial and error. Now, a new diagnostic test can take the guess work out of prescr...

We are committed to recognizing and valuing our team members and championing their diverse voices and experiences. Earlier this week, team members met in Boston for Diversity, Equity, Inclusion, and Belonging (DEIB) training.